Literature DB >> 25656940

Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats.

Jun Wang1, Mingxia Bi, Junxia Xie.   

Abstract

Elevated iron levels in the substantia nigra (SN) participate in neuronal death in Parkinson's disease (PD), while the mechanisms underlying the increased iron are still unknown. Ceruloplasmin (CP), a ferroxidase, converts highly toxic ferrous iron to its non-toxic ferric form, which cooperated with ferroportin1 (FP1) facilitating the export of iron from cells. To elucidate if the abnormal expression of CP is involved in the nigral iron accumulation, here, we investigated CP expression in the SN of rats lesioned by 6-hydroxydopamine (6-OHDA). We showed that FP1 and CP colocalized in the rat SN. One day after 6-OHDA lesion, when there was a half reduction in the number of dopaminergic neurons, the iron level was increased compared with the normal rats; both the mRNA and protein expressions of CP decreased compared with the control. When rats began showing rotation behavior induced by apomorphine, usually after 6 weeks since 6-OHDA lesion, they are considered PD models. In these PD models, almost no dopaminergic neurons can be detected in the lesioned SN and nigral iron level was further increased. At this time point, a further decrease of CP was observed. These results show that FP1 and CP colocalize in the rat brain, indicating the coordinated actions of the two proteins in the cellular iron export, and suggest that decreased expression of CP in the SN is involved in the nigral iron accumulation of 6-OHDA-lesioned rats.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25656940     DOI: 10.1007/s10571-015-0161-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  46 in total

Review 1.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.

Authors:  Xueying Xu; Sokhon Pin; Muraya Gathinji; Ralph Fuchs; Z Leah Harris
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 2.  Ferroportin1: a new iron export molecule?

Authors:  Nghia T V Le; Des R Richardson
Journal:  Int J Biochem Cell Biol       Date:  2002-02       Impact factor: 5.085

3.  A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.

Authors:  K Yoshida; K Furihata; S Takeda; A Nakamura; K Yamamoto; H Morita; S Hiyamuta; S Ikeda; N Shimizu; N Yanagisawa
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

4.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  Iron on the brain.

Authors:  T A Rouault
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

Review 6.  Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.

Authors:  Amit Pal; Ashok Kumar; Rajendra Prasad
Journal:  Biometals       Date:  2014-01-17       Impact factor: 2.949

7.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.

Authors:  C D Vulpe; Y M Kuo; T L Murphy; L Cowley; C Askwith; N Libina; J Gitschier; G J Anderson
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

8.  Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats.

Authors:  Y Zhou; Z Q Zhao; J X Xie
Journal:  Brain Res       Date:  2001-10-26       Impact factor: 3.252

9.  Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.

Authors:  Na Zhao; Lirong Jin; Guoqiang Fei; Zhiyong Zheng; Chunjiu Zhong
Journal:  Parkinsonism Relat Disord       Date:  2014-09-01       Impact factor: 4.891

10.  Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease.

Authors:  Scott Ayton; Peng Lei; Paul A Adlard; Irene Volitakis; Robert A Cherny; Ashley I Bush; David I Finkelstein
Journal:  Mol Neurodegener       Date:  2014-07-10       Impact factor: 14.195

View more
  8 in total

Review 1.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

2.  DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson's disease.

Authors:  Chun-Bo Hu; Hui Jiang; Yin Yang; Guo-Hua Wang; Qiu-Hong Ji; Zhong-Zheng Jia; Li-Hua Shen; Qian-Qian Luo
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 3.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

4.  Involvement of Ventral Periaqueductal Gray Dopaminergic Neurons in Propofol Anesthesia.

Authors:  Jia Li; Tian Yu; Fu Shi; Yu Zhang; Zikun Duan; Bao Fu; Yi Zhang
Journal:  Neurochem Res       Date:  2018-02-07       Impact factor: 3.996

Review 5.  New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.

Authors:  Huamin Xu; Hong Jiang; Junxia Xie
Journal:  Front Mol Neurosci       Date:  2017-03-16       Impact factor: 5.639

6.  Mapping Chemical Elements and Iron Oxidation States in the Substantia Nigra of 6-Hydroxydopamine Lesioned Rats Using Correlative Immunohistochemistry With Proton and Synchrotron Micro-Analysis.

Authors:  Asuncion Carmona; Stéphane Roudeau; Laura Perrin; Carole Carcenac; Delphine Vantelon; Marc Savasta; Richard Ortega
Journal:  Front Neurosci       Date:  2019-09-26       Impact factor: 4.677

Review 7.  Aberrant Cerebral Iron Trafficking Co-morbid With Chronic Inflammation: Molecular Mechanisms and Pharmacologic Intervention.

Authors:  Shaina L Rosenblum; Daniel J Kosman
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

8.  Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition.

Authors:  Xin Li; Xiao-Wen Jiang; Hai-Xiao Chu; Qing-Chun Zhao; Huai-Wei Ding; Chao-Hong Cai
Journal:  Chin Herb Med       Date:  2020-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.